On Tuesday, Integra Lifesciences Holdings Corp (NASDAQ: IART) opened higher 1.51% from the last session, before settling in for the closing price of $19.22. Price fluctuations for IART have ranged from $16.81 to $45.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.17%. Company’s average yearly earnings per share was noted -21.02% at the time writing. With a float of $65.08 million, this company’s outstanding shares have now reached $78.17 million.
The extent of productivity of a business whose workforce counts for 5329 workers is very important to gauge. In terms of profitability, gross margin is 56.92%, operating margin of 7.77%, and the pretax margin is 1.73%.
Integra Lifesciences Holdings Corp (IART) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Integra Lifesciences Holdings Corp is 16.12%, while institutional ownership is 90.63%. The most recent insider transaction that took place on Aug 19 ’24, was worth 25,701. In this transaction SVP, Fin & Princ Acct Officer of this company sold 1,191 shares at a rate of $21.58, taking the stock ownership to the 36,088 shares. Before that another transaction happened on May 23 ’24, when Company’s Exec. Chairman of the Board bought 52,641 for $28.49, making the entire transaction worth $1,499,979. This insider now owns 487,922 shares in total.
Integra Lifesciences Holdings Corp (IART) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -21.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.18% during the next five years compared to 3.10% growth over the previous five years of trading.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Check out the current performance indicators for Integra Lifesciences Holdings Corp (IART). In the past quarter, the stock posted a quick ratio of 2.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.97. Likewise, its price to free cash flow for the trailing twelve months is 25.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.30, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 2.50 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
The latest stats from [Integra Lifesciences Holdings Corp, IART] show that its last 5-days average volume of 1.06 million was inferior to 1.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.47%. Additionally, its Average True Range was 0.76.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 17.06%, which indicates a significant decrease from 85.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.28% in the past 14 days, which was lower than the 48.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.20, while its 200-day Moving Average is $30.17. Now, the first resistance to watch is $19.82. This is followed by the second major resistance level at $20.14. The third major resistance level sits at $20.56. If the price goes on to break the first support level at $19.09, it is likely to go to the next support level at $18.67. The third support level lies at $18.35 if the price breaches the second support level.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
There are currently 78,800K shares outstanding in the company with a market cap of 1.51 billion. Presently, the company’s annual sales total 1,542 M according to its annual income of 67,740 K. Last quarter, the company’s sales amounted to 418,180 K and its income totaled -12,400 K.
